Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: Beneficial effect seen on chronic GVHD

Bone Marrow Transplantation

Volumn 45, Issue 1, 2010, Pages 205-207

  Rodriguez, R ^a,b   Nademanee, A ^a   Palmer, J M ^a   Parker, P ^a   Nakamura, R ^a   Snyder, D ^a   Pullarkat, V ^a   Zain, J ^a   Smith, E ^a   Sahebi, F ^a   Patane, K ^a   Senitzer, D ^a   Chang, K ^a   Forman, S J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DIPHENHYDRAMINE; FLUDARABINE; MELPHALAN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; DRUG DOSE ESCALATION; ENGRAFTMENT; EPSTEIN BARR VIRUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HODGKIN DISEASE; HUMAN; INFECTIOUS PNEUMONIA; LETTER; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY OF LIFE; REDUCED INTENSITY CONDITIONING; SINGLE DRUG DOSE; VIRUS INFECTION; VIRUS REACTIVATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 75149135631     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.112     Document Type: Letter

References (10)

1. Storb R, Sale G, Barnett T, Yu C, Zellmer E, Little MT. Transient mixed hematopoietic chimerism in dogs given thymic irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 2001; 97: 2915-2916.
2. Rodriguez R, Parker P, Nademanee A, Smith D, O'Donnell MR, Stein A et al. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. Bone Marrow Transplant 2004; 33: 1123-1129.
3. Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE et al. Thymoglobulin prevents chronic graftversus- host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560-565.
4. Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C et al. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant 2007; 13: 299-306.
5. Deeg HJ, Storer BE, Boeckh M, Martin PJ, McCune JS, Myerson D et al. Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. Biol Blood Marrow Transplant 2006; 12: 573-584.
6. Preville X, Flacher M, LeMauff B, Beauchard S, Davelu P, Tiollier J et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001; 71: 460-468.
7. Klaus G, Mostert K, Reckzeh B, Mueller TF. Phenotypic changes in lymphocyte subpopulations in pediatric renaltransplant patients after T-cell depletion. Transplantation 2003; 76: 1719-1724.
8. Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL et al. Immunocompetent T-cells with a memorylike phenotype are the dominant cell type following antibodymediated T-cell depletion. Am J Transplant 2005; 5: 465-474.
9. Zand MS. B-cell activity of polyclonal antithymocyte globulins. Transplantation 2006; 82: 1387-1395.
10. Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D et al. Rituximab for steroid-refractory chronic graft-versushost disease. Blood 2006; 108: 756-762.